Related Experiment Video
Updated: Apr 17, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer
Shane Stegeman1, Leire Moya1, Luke A Selth2
1School of Biomedical SciencesInstitute of Health and Biomedical Innovation, Translational Research Institute Pty Ltd, Australian Prostate Cancer Research Centre - Queensland, Queensland University of Technology, 37 Kent Street, Woolloongabba, Brisbane, Queensland 4102, AustraliaDame Roma Mitchell Cancer Research LaboratoriesSchool of Medicine, Adelaide Prostate Cancer Research CentreSchool of MedicineFreemasons Foundation Centre for Men's Health, The University of Adelaide, Adelaide, South Australia 5005, AustraliaMolecular Cancer Epidemiology LaboratoryGenetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia.
Abstract:
The oncogene MDM4, also known as MDMX or HDMX, contributes to cancer susceptibility and progression through its capacity to negatively regulate a range of genes with tumour-suppressive functions. As part of a recent genome-wide association study it was determined that the A-allele of the rs4245739 SNP (A>C), located in the 3'-UTR of MDM4, is associated with an increased risk of prostate cancer. Computational predictions revealed that the rs4245739 SNP is located within a predicted binding site for three microRNAs (miRNAs): miR-191-5p, miR-887 and miR-3669. Herein, we show using reporter gene assays and endogenous MDM4 expression analyses that miR-191-5p and miR-887 have a specific affinity for the rs4245739 SNP C-allele in prostate cancer. These miRNAs do not affect MDM4 mRNA levels, rather they inhibit its translation in C-allele-containing PC3 cells but not in LNCaP cells homozygous for the A-allele. By analysing gene expression datasets from patient cohorts, we found that MDM4 is associated with metastasis and prostate cancer progression and that targeting this gene with miR-191-5p or miR-887 decreases in PC3 cell viability. This study is the first, to our knowledge, to demonstrate regulation of the MDM4 rs4245739 SNP C-allele by two miRNAs in prostate cancer, and thereby to identify a mechanism by which the MDM4 rs4245739 SNP A-allele may be associated with an increased risk for prostate cancer.
Insights
The oncogene MDM4 is linked to increased prostate cancer risk via the rs4245739 SNP. Specific microRNAs target the C-allele, inhibiting MDM4 translation and affecting cancer progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- The MDM4 oncogene (also known as MDMX or HDMX) plays a role in cancer by suppressing tumor-suppressive genes.
- A genome-wide association study identified the rs4245739 SNP (A>C) in MDM4's 3'-UTR, with the A-allele associated with higher prostate cancer risk.
Purpose of the Study:
- To investigate the functional impact of the rs4245739 SNP on MDM4 regulation by microRNAs (miRNAs) in prostate cancer.
- To elucidate the mechanism by which the rs4245739 SNP A-allele might contribute to prostate cancer susceptibility.
Main Methods:
- Reporter gene assays and endogenous MDM4 expression analysis were used to assess miRNA binding and effects.
- Computational predictions identified potential miRNA binding sites at the rs4245739 SNP.
- Analysis of patient gene expression datasets correlated MDM4 with prostate cancer progression and metastasis.
Main Results:
- miR-191-5p and miR-887 specifically bind to the rs4245739 SNP C-allele in prostate cancer cells.
- These miRNAs inhibit MDM4 translation, not mRNA levels, in C-allele-containing PC3 cells.
- MDM4 expression correlates with metastasis and progression; targeting MDM4 with miR-191-5p or miR-887 reduces PC3 cell viability.
Conclusions:
- This study demonstrates miRNA-mediated regulation of the MDM4 rs4245739 SNP C-allele in prostate cancer.
- A mechanism is identified where specific miRNAs targeting the C-allele may explain the association of the A-allele with increased prostate cancer risk.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Master Transcription Regulators
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

